FDA Rules Silicone Breast Implants To Stay On Market

Silicone gel breast implants will remain on the U.S. market while manufacturers work to boost participation rates in required long-term studies, a Food and Drug Administration (FDA) official said.

"FDA continues to believe currently approved devices are safe and effective," said William Maisel, FDA's chief scientist and deputy director in the agency's device division. But he added, "there is a significant complication rate."

More